和铂医药-B(02142.HK)11月6日耗资127.8万港元回购10万股

Core Viewpoint - Heptagon Pharmaceuticals-B (02142.HK) announced a share buyback of 100,000 shares at a cost of HKD 1.278 million on November 6 [1] Group 1 - The company executed a buyback program, indicating a commitment to returning value to shareholders [1] - The total expenditure for the buyback was HKD 1.278 million, reflecting the company's financial strategy [1] - The number of shares repurchased was 100,000, which may influence the stock's market performance [1]